PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Nuclear Signaling Lab., Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Melbourne, Australia. Electronic address: David.Jans@monash.edu.\', \'Cancer Targeting and Nuclear Therapeutics Lab., Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Melbourne, Australia. Electronic address: Kylie.Wagstaff@monash.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0006-291X(20)31959-810.1016/j.bbrc.2020.10.042
?:doi
?:hasPublicationType
?:journal
  • Biochemical and biophysical research communications
is ?:pmid of
?:pmid
?:pmid
  • 33341233
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.087
?:rankingScore_hIndex
  • 237
is ?:relation_isRelatedTo_publication of
?:title
  • The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all